| Autocrine semaphorin 3A signaling promotes glioblastoma dispersal T Bagci, JK Wu, R Pfannl, LL Ilag, DG Jay Oncogene 28 (40), 3537-3550, 2009 | 156 | 2009 |
| A Dual PI3K/mTOR Inhibitor, PI-103, Cooperates with Stem Cell–Delivered TRAIL in Experimental Glioma Models T Bagci-Onder, H Wakimoto, M Anderegg, C Cameron, K Shah Cancer research 71 (1), 154-163, 2011 | 137 | 2011 |
| Tumor cell infiltration into the brain in glioblastoma: from mechanisms to clinical perspectives F Seker-Polat, N Pinarbasi Degirmenci, I Solaroglu, T Bagci-Onder Cancers 14 (2), 443, 2022 | 135 | 2022 |
| Therapeutic stem cells expressing variants of EGFR-specific nanobodies have antitumor effects JAJM van de Water, T Bagci-Onder, AS Agarwal, H Wakimoto, ... Proceedings of the National Academy of Sciences 109 (41), 16642-16647, 2012 | 111 | 2012 |
| Genome-wide CRISPR screen identifies PRC2 and KMT2D-COMPASS as regulators of distinct EMT trajectories that contribute differentially to metastasis Y Zhang, JL Donaher, S Das, X Li, F Reinhardt, JA Krall, AW Lambert, ... Nature cell biology 24 (4), 554-564, 2022 | 79 | 2022 |
| IDH Mutations in Glioma: Double-Edged Sword in Clinical Applications? A Kayabolen, E Yilmaz, T Bagci-Onder Biomedicines 9 (7), 799, 2021 | 71 | 2021 |
| Identification of SERPINE1 as a regulator of glioblastoma cell dispersal with transcriptome profiling F Seker, A Cingoz, I Sur-Erdem, N Erguder, A Erkent, F Uyulur, ... Cancers 11 (11), 1651, 2019 | 64 | 2019 |
| Epigenetic deregulation of apoptosis in cancers E Ozyerli-Goknar, T Bagci-Onder Cancers 13 (13), 3210, 2021 | 58 | 2021 |
| Real-time imaging of the dynamics of death receptors and therapeutics that overcome TRAIL resistance in tumors T Bagci-Onder, A Agarwal, D Flusberg, S Wanningen, P Sorger, K Shah Oncogene 32 (23), 2818-2827, 2013 | 51 | 2013 |
| Gelatin methacryloyl hydrogels in the absence of a crosslinker as 3D glioblastoma multiforme (GBM)‐mimetic microenvironment P Erkoc, F Seker, T Bagci‐Onder, S Kizilel Macromolecular bioscience 18 (3), 1700369, 2018 | 50 | 2018 |
| Identification of CD44 as a surface biomarker for drug resistance by surface proteome signature technology JW Cain, RS Hauptschein, JK Stewart, T Bagci, GG Sahagian, DG Jay Molecular Cancer Research 9 (5), 637-647, 2011 | 50 | 2011 |
| May iron (III) complexes containing phenanthroline derivatives as ligands be prospective anticancer agents? CP Matos, Z Adiguzel, Y Yildizhan, B Cevatemre, TB Onder, O Cevik, ... European Journal of Medicinal Chemistry 176, 492-512, 2019 | 46 | 2019 |
| Targeting breast to brain metastatic tumours with death receptor ligand expressing therapeutic stem cells T Bagci-Onder, W Du, JL Figueiredo, J Martinez-Quintanilla, K Shah Brain 138 (6), 1710-1721, 2015 | 45 | 2015 |
| The pro-apoptotic Bcl-2 family member Harakiri (HRK) induces cell death in glioblastoma multiforme E Kaya-Aksoy, A Cingoz, F Senbabaoglu, F Seker, I Sur-Erdem, ... Cell death discovery 5 (1), 64, 2019 | 44 | 2019 |
| Systematic characterization of chromatin modifying enzymes identifies KDM3B as a critical regulator in castration resistant prostate cancer H Saraç, T Morova, E Pires, J McCullagh, A Kaplan, A Cingöz, ... Oncogene 39 (10), 2187-2201, 2020 | 43 | 2020 |
| Identification of Mitoxantrone as a TRAIL-sensitizing agent for Glioblastoma Multiforme F Senbabaoglu, A Cingoz, E Kaya, S Kazancioglu, NA Lack, C Acilan, ... Cancer biology & therapy 17 (5), 546-557, 2016 | 40 | 2016 |
| Biochemical and proteomic analysis of a potential anticancer agent: Palladium (II) Saccharinate complex of terpyridine acting through double strand break formation Z Adiguzel, AT Baykal, O Kacar, VT Yilmaz, E Ulukaya, C Acilan Journal of proteome research 13 (11), 5240-5249, 2014 | 39 | 2014 |
| KDM2B, an H3K36-specific demethylase, regulates apoptotic response of GBM cells to TRAIL IC Kurt, I Sur, E Kaya, A Cingoz, S Kazancioglu, Z Kahya, OD Toparlak, ... Cell Death & Disease 8 (6), e2897-e2897, 2017 | 37 | 2017 |
| Quinacrine Mediated Sensitization of Glioblastoma (GBM) Cells to TRAIL through MMP‐Sensitive PEG Hydrogel Carriers P Erkoc, A Cingöz, T Bagci‐Onder, S Kizilel Macromolecular Bioscience 17 (2), 1600267, 2017 | 36 | 2017 |
| Glioma-on-a-chip models M Ustun, S Rahmani Dabbagh, IS Ilci, T Bagci-Onder, S Tasoglu Micromachines 12 (5), 490, 2021 | 31 | 2021 |